Correlation between follicular fluid 25-hydroxyvitamin D levels and IVF embryo quality in women with diminished ovarian reserve: A metabolomic study
Introduction: Improving pregnancy outcomes for women with diminished ovarian reserve (DOR) is a key area of focus in assisted reproductive technology (ART).
Objective: This study aims to investigate the association between 25-hydroxyvitamin D (25-[OH]D) levels in follicular fluid (FF) of women with diminished ovarian reserve (DOR) and embryo quality during in vitro fertilization (IVF), and to perform a metabolomics analysis.
Methods: A total of 54 women with DOR and 62 women with normal ovarian reserve (control) were enrolled. Based on FF 25-(OH)D levels, both DOR and control cases were stratified into two subgroups: the vitamin D non-deficient (VDH) and vitamin D deficient (VDL). Baseline characteristics and IVF laboratory outcomes were compared among groups and subgroups. Untargeted metabolomic profiling of FF was then performed to identify differences between subgroups.
Results: FF vitamin D levels were significantly lower in the DOR group than in controls. In both cohorts, the normal fertilization rate was significantly higher in the VDH subgroup than in the VDL subgroup. Metabolites significantly upregulated in the VDH subgroup included phospholipids, hydroxychloroquine, and serinyltryptophan. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis revealed significant enrichment in glycerophospholipid metabolism in the VDH subgroup. In the DOR group, the DOR-VDH subgroup exhibited upregulation of steroid hormone biosynthesis and vitamin metabolism pathways, particularly those mediated by cytochrome P450, relative to the DOR-VDL subgroup.
Conclusion: Vitamin D may enhance the follicular microenvironment in DOR patients primarily by regulating lipid metabolism, thereby improving oocyte and embryo quality and developmental potential.
- Pastore LM, Christianson MS, Stelling J, et al. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J Assist Reprod Genet. 2018;35(1):17-23. doi: 10.1007/s10815-017-1058-4
- Dogan S, Cicek OSY, Demir M, et al. The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response. J Gynecol Obstet Hum Reprod. 2021;50(2):101982. doi: 10.1016/j.jogoh.2020.101982
- Xie Y, Shi W, Tan Y, et al. Acupuncture and moxibustion for diminished ovarian reserve: A scoping review. Complement Ther Med. 2023;77:102973. doi: 10.1016/j.ctim.2023.102973
- Fichera M, Torok P, Tesarik J, et al. Vitamin D, reproductive disorders and assisted reproduction: evidences and perspectives. Int J Food Sci Nutr. 2020;71(3):276-285. doi: 10.1080/09637486.2019.1661978
- Da Silveira EA, Moura L, Castro MCR, et al. Prevalence of Vitamin D and Calcium Deficiency and Insufficiency in Women of Childbearing Age and Associated Risk Factors: A Systematic Review and Meta-Analysis. Nutrients. 2022;14(20):4351. doi: 10.3390/nu14204351
- Moridi I, Chen A, Tal O, et al. The Association between Vitamin D and Anti-Mullerian Hormone: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(6):1567. doi: 10.3390/nu12061567
- Van Tienhoven XA, Ruiz de Chavez Gascon J, Cano-Herrera G, et al. Vitamin D in Reproductive Health Disorders: A Narrative Review Focusing on Infertility, Endometriosis, and Polycystic Ovarian Syndrome. Int J Mol Sci. 2025;26(5):2256. doi: 10.3390/ijms26052256
- Yang M, Shen X, Lu D, et al. Effects of vitamin D supplementation on ovulation and pregnancy in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1148556. doi: 10.3389/fendo.2023.1148556
- Chinese Society of Endocrinology. Expert Consensus on the Evaluation and Improvement of Vitamin D Nutritional Status (2023). Chin J Endocrinol Metab. 2023;39(3):193-203. doi: 10.3760/cma.j.cn115624-20230105-00003
- Da Broi MG, Giorgi VSI, Wang F, et al. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet. 2018;35(5):735-751. doi: 10.1007/s10815-018-1143-3
- Lagana AS, Vitale SG, Ban Frangež H, et al. Vitamin D in human reproduction: the more, the better? An evidencebased critical appraisal. Eur Rev Med Pharmacol Sci. 2017;21(18):4243-4251.
- Bacanakgil BH, İlhan G, Ohanoğlu K. Effects of vitamin D supplementation on ovarian reserve markers in infertile women with diminished ovarian reserve. Medicine. 2022;101(6):e28796. doi: 10.1097/md.0000000000028796
- Arefi S, Khalili G, Iranmanesh H, et al. Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population? J Ovarian Res. 2018;11(1):62. doi: 10.1186/s13048-018-0435-7
- Hasan HA, Barber TM, Cheaib S, et al. Preconception Vitamin D Level and In Vitro Fertilization: Pregnancy Outcome. Endocr Pract. 2023;29(4):235-239. doi: 10.1016/j.eprac.2023.01.005
- Faisal R, Alhalabi M, Alquobaili F. Correlation between 25-hydroxy vitamin D levels in women and in vitro fertilization outcomes: A cross-sectional study. Ann Med Surg. 2022;80:104126. doi: 10.1016/j.amsu.2022.104126
- Antunes RA, Melo BML, Souza M, et al. Vitamin D and follicular recruitment in the in vitro fertilization cycle. JBRA Assist Reprod. 2024;28(2):269-275. doi: 10.5935/1518-0557.20240005
- Skowrońska P, Kunicki M, Pastuszek E, et al. Vitamin D and anti-Mullerian hormone concentration in human follicular fluid individually aspirated from all patient follicles. Gynecol Endocrinol. 2022;38(1):28-32. doi: 10.1080/09513590.2021.1933934
- Ciepiela P, Dulęba AJ, Kowaleczko E, et al. Vitamin D as a follicular marker of human oocyte quality and a serum marker of in vitro fertilization outcome. J Assist Reprod Genet. 2018;35(7):1265-1276. doi: 10.1007/s10815-018-1179-4
- Karimi E, Arab A, Rafiee M, et al. A systematic review and meta-analysis of the association between vitamin D and ovarian reserve. Sci Rep. 2021;11(1):16005. doi: 10.1038/s41598-021-95481-x
- Bao S, Yin T, Liu S. Ovarian aging: energy metabolism of oocytes. J Ovarian Res. 2024;17(1):118. doi: 10.1186/s13048-024-01427-y
- Warzych E, Lipinska P. Energy metabolism of follicular environment during oocyte growth and maturation. J Reprod Dev. 2020;66(1):1-7. doi: 10.1262/jrd.2019-102
- Khan R, Jiang X, Hameed U, et al. Role of Lipid Metabolism and Signaling in Mammalian Oocyte Maturation, Quality, and Acquisition of Competence. Front Cell Dev Biol. 2021;9:639704. doi: 10.3389/fcell.2021.639704
- Richani D, Dunning KR, Thompson JG, et al. Metabolic co-dependence of the oocyte and cumulus cells: essential role in determining oocyte developmental competence. Hum Reprod Update. 2021;27(1):27-47. doi: 10.1093/humupd/dmaa043
- Nandi A, Wadhwani N, Joshi SR. Vitamin D deficiency influences fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids. 2019;140:57-63. doi: 10.1016/j.plefa.2018.11.014
- Nema J, Randhir K, Wadhwani N, et al. Maternal vitamin D deficiency reduces docosahexaenoic acid, placental growth factor and peroxisome proliferator activated receptor gamma levels in the pup brain in a rat model of preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2021;175:102364. doi: 10.1016/j.plefa.2021.102364
- Nandi AA, Wadhwani NS, Joshi SR. Maternal vitamin D deficiency increases the thromboxane/prostacyclin ratio through alterations in the one-carbon cycle in Wistar rats. Biofactors. 2019;45(4):548-555. doi: 10.1002/biof.1510
- Nandi AA, Wadhwani NS, Randhir KN, et al. Maternal vitamin D deficiency influences long-chain polyunsaturated fatty acids and pregnancy outcome in association with alterations in one-carbon metabolism. Nutr Res. 2021;86:37-49. doi: 10.1016/j.nutres.2020.11.009
- Sarkar C, Lipinski MM. Glycerophospholipid dysregulation after traumatic brain injury. Neurochem Int. 2024;175:105701. doi: 10.1016/j.neuint.2024.105701
- Wu J, Zhao X, Fang Y, et al. GPD1L-Mediated Glycerophospholipid Metabolism Dysfunction in Women With Diminished Ovarian Reserve: Insights From Pseudotargeted Metabolomic Analysis of Follicular Fluid. Cell Prolif. 2025;58(9):e70024. doi: 10.1111/cpr.70024
- Wang P, Qin X, Liu M, et al. The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer. Pharmacol Res. 2018;133:9-20. doi: 10.1016/j.phrs.2018.04.022
- Abdelrahman BA, Hammam OA, El-Khatib AS, et al. The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH. Biochem Biophys Res Commun. 2023;688:149122. doi: 10.1016/j.bbrc.2023.149122
- Dimitrov V, Barbier C, Ismailova A, et al. Vitamin D-regulated Gene Expression Profiles: Species specificity and Cell-specific Effects on Metabolism and Immunity. Endocrinology. 2021;162(2):bqaa218. doi: 10.1210/endocr/bqaa218
- Beaudin S, Welsh J. 1,25-Dihydroxyvitamin D Regulation of Glutamine Synthetase and Glutamine Metabolism in Human Mammary Epithelial Cells. Endocrinology. 2017;158(12):4174-4188. doi: 10.1210/en.2017-00238
- Kopp L, Schweinlin A, Tingo L, et al. Potential Modulation of Inflammation and Physical Function by Combined Probiotics, Omega-3 Supplementation and Vitamin D Supplementation in Overweight/Obese Patients with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial. Int J Mol Sci. 2023;24(10):8567. doi: 10.3390/ijms24108567
- Rendic S, Guengerich FP. Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters. Curr Drug Metab. 2020;21(14):1127-1135. doi: 10.2174/1389200221999201208211537
- Wang R, Qi S, Wang Q, et al. Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome. BMC Endocr Disord. 2025;25(1):2. doi: 10.1186/s12902-024-01827-7
